From: The role of extracellular vesicles in osteoarthritis treatment via microenvironment regulation
EV Source | miRNA | Selected animals model in vivo | Role | Pathway | Effect | Reference |
---|---|---|---|---|---|---|
UMSCs | lncRNA H19 | SD Rats | Promote chondrocyte migration and matrix secretion and inhibit cell apoptosis and senescence | miR-29b-3p/FOXO3 | Promote sustained cartilage repair | [86] |
AD-MSCs | miR-100-5p | C57BL/6 mice | Promote the proliferation of chondrocytes, increase the level of chondrocytes autophagy, enhance matrix synthesis, and reduce the expression of metabolic factors | mTOR signaling pathway | Protect articular cartilage from damage and ameliorate gait abnormality | [78] |
S-MSCs | miR-140-5p | SD rats | Increase the proliferation and migration of chondrocytes | Wnt signaling pathway | Successfully prevent OA | [73] |
S-MSCs | miR-155-5p | BALB/C mice | Promote the proliferation and migration of chondrocytes and inhibit cell apoptosis | Runx2 | Prevent OA | [75] |
hBM-MSCs | miR-136-5p | C57BL/6 mice | Promote the migration of chondrocytes and inhibit chondrocytes degeneration | Targets ELF3 | Prevent traumatic OA | [150] |
MSCs | miR-135b | SD rats | Promote chondrocyte proliferation and inhibit cartilage degradation | Sp1 | Promote cartilage repair | [81] |
hMSCs | miR-206 | C57BL/6 mice | Promote chondrocyte proliferation and inhibit chondrocyte apoptosis | KLF3-AS1/miR-206/GIT1 axis | Attenuate chondrocyte injury | [19] |